Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial. Lancet. 2004 Aug 21-27; 364(9435):675-84.

View in: PubMed

subject areas

Aged
Anti-Inflammatory Agents, Non-Steroidal
Aspirin
Cyclooxygenase Inhibitors
Diclofenac
Double-Blind Method
Female
Humans
Ibuprofen
Male
Middle Aged
Myocardial Infarction
Naproxen
Organic Chemicals
Osteoarthritis
Platelet Aggregation Inhibitors
Risk Factors
Stroke

authors with profiles

Robert Harrington